Menu
Back to Journals » Drug Design, Development and Therapy » Volume 12
Review
Inotuzumab ozogamicin: a CD22 mAb–drug conjugate for adult relapsed or refractory B-cell precursor acute lymphoblastic leukemia
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 20,407 | Dovepress* | 15,797+ | 1,418 | 17,215 | |
| PubMed Central* | 4,610 | 885 | 5,495 | ||
| Totals | 20,407 | 2,303 | 22,710 | ||
| *Since 24 July 2018 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 6 | 0 | 0 | 0 | 2 | 4 |
View citations on PubMed Central and Google Scholar